Ausgabe 2/2018
Inhalt (27 Artikel)
Racial disparities in chemotherapy administration for early-stage breast cancer: a systematic review and meta-analysis
Angela K. Green, Emeline M. Aviki, Konstantina Matsoukas, Sujata Patil, Deborah Korenstein, Victoria Blinder
Neoadjuvant therapy for breast cancer treatment: an expert panel recommendation from the Brazilian Society of Breast Surgeons 2018
Fernanda Barbosa C Rocha, Ana Beatriz Falcone, Antonio Carlos Buzaid, Juliana Martins Pimenta, Gustavo Schvartsman, Antonio Luiz Frasson
Chronologically changing patterns in the survival of korean patients with breast cancer and related clinical factors: a nationwide registry-based study
Sae Byul Lee, Seung Sang Ko, Chan Heun Park, Seok Jin Nam, Jung Eun Choi, Yong Sik Jung, Woo-Chan Park, Byung Ho Son
The prognostic value of androgen receptors in breast cancer subtypes
Maria Ryssdal Kraby, Marit Valla, Signe Opdahl, Olav Anton Haugen, Joanna Ewa Sawicka, Monica Jernberg Engstrøm, Anna Mary Bofin
Fluidic shear stress increases the anti-cancer effects of ROS-generating drugs in circulating tumor cells
Sagar Regmi, To Sing Fung, Sierin Lim, Kathy Qian Luo
Co-expressed genes enhance precision of receptor status identification in breast cancer patients
Michael Kenn, Dan Cacsire Castillo-Tong, Christian F. Singer, Michael Cibena, Heinz Kölbl, Wolfgang Schreiner
Comparison of central laboratory assessments of ER, PR, HER2, and Ki67 by IHC/FISH and the corresponding mRNAs (ESR1, PGR, ERBB2, and MKi67) by RT-qPCR on an automated, broadly deployed diagnostic platform
Natalie C. Wu, Wendy Wong, Kenneth E. Ho, Victor C. Chu, Annaliza Rizo, Simon Davenport, Devon Kelly, Rosemary Makar, Jacek Jassem, Renata Duchnowska, Wojciech Biernat, Barbara Radecka, Tomoyuki Fujita, Jonathan L. Klein, Mark Stonecypher, Shoichiro Ohta, Hartmut Juhl, Jodi M. Weidler, Michael Bates, Michael F. Press
Somatic EP300-G211S mutations are associated with overall somatic mutational patterns and breast cancer specific survival in triple-negative breast cancer
Vahid Bemanian, John Christopher Noone, Torill Sauer, Joel Touma, Katja Vetvik, Cecilia Søderberg-Naucler, Jonas Christoffer Lindstrøm, Ida Rashida Bukholm, Vessela N. Kristensen, Jürgen Geisler
Therapeutic predictors of neoadjuvant endocrine therapy response in estrogen receptor-positive breast cancer with reference to optimal gene expression profiling
Lisa Goto-Yamaguchi, Mutsuko Yamamoto-Ibusuki, Yutaka Yamamoto, Yoshitaka Fujiki, Mai Tomiguchi, Aiko Sueta, Takashi Takeshita, Hirotaka Iwase
Gray matter density reduction associated with adjuvant chemotherapy in older women with breast cancer
Bihong T. Chen, Taihao Jin, Sunita K. Patel, Ningrong Ye, Can-Lan Sun, Huiyan Ma, Russell C. Rockne, James C. Root, Andrew J. Saykin, Tim A. Ahles, Andrei I. Holodny, Neal Prakash, Joanne Mortimer, James Waisman, Yuan Yuan, Daneng Li, George Somlo, Jessica Vazquez, Abrahm Levi, Heidi Tan, Richard Yang, Vani Katheria, Arti Hurria
Letrozole concentration is associated with CYP2A6 variation but not with arthralgia in patients with breast cancer
Adrienne E. Borrie, Rhiannon V. Rose, Yun-Hee Choi, Francisco E. Perera, Nancy Read, Tracy Sexton, Michael Lock, Theodore A. Vandenberg, Karin Hahn, Robert Dinniwell, Jawaid Younus, Diane Logan, Kylea Potvin, Brian Yaremko, Edward Yu, John Lenehan, Stephen Welch, Rachel F. Tyndale, Wendy A. Teft, Richard B. Kim
A comparison of the imaging features of pleomorphic and classical invasive lobular carcinoma
Phey Ming Yeap, Andrew Evans, Colin A. Purdie, Lee B. Jordan, Sarah J. Vinnicombe
Predicting efficacy of epirubicin by a multigene assay in advanced breast cancer within a Danish Breast Cancer Cooperative Group (DBCG) cohort: a retrospective-prospective blinded study
Anna Sofie Kappel Buhl, Troels Dreier Christensen, Ib Jarle Christensen, Knud Mejer Nelausen, Eva Balslev, Ann Søegaard Knoop, Eva Harder Brix, Else Svensson, Vesna Glavicic, Adam Luczak, Sven Tyge Langkjer, Søren Linnet, Erik Hugger Jakobsen, Jurij Bogovic, Bent Ejlertsen, Annie Rasmussen, Anker Hansen, Steen Knudsen, Dorte Nielsen, Peter Buhl Jensen
Genetic polymorphisms of 3′-untranslated region of SULT1A1 and their impact on tamoxifen metabolism and efficacy
A. B. Sanchez-Spitman, V. O. Dezentjé, J. J. Swen, D. J. A. R. Moes, H. Gelderblom, Henk-Jan Guchelaar
Intermittent versus continuous first-line treatment for HER2-negative metastatic breast cancer: the Stop & Go study of the Dutch Breast Cancer Research Group (BOOG)
Anouk K. M. Claessens, Monique E. M. M. Bos, Marta Lopez-Yurda, Jeanette M. Bouma, Jeany M. Rademaker-Lakhai, Aafke H. Honkoop, Hiltje de Graaf, Edith van Druten, Laurence J. C. van Warmerdam, Maurice J. C. van der Sangen, Vivianne C. G. Tjan-Heijnen, Frans L. G. Erdkamp
Prognostic impact of skeletal muscle volume derived from cross-sectional computed tomography images in breast cancer
Eun Jin Song, Chan Wha Lee, So-Youn Jung, Byeong Nam Kim, Keun Seok Lee, Seeyoun Lee, Han-Sung Kang, In Hae Park, Moo Hyun Lee, Yun Ju Kim, Kyungran Ko, Sohee Kim, Byung-Ho Nam, Eun Sook Lee
Differences in prognosis and efficacy of chemotherapy by p53 expression in triple-negative breast cancer
Soo Youn Bae, Seok Jin Nam, Yongsik Jung, Sae Byul Lee, Byung-Woo Park, Woosung Lim, Sung Hoo Jung, Hsien Wen Yang, Seung Pil Jung
Impact of primary breast cancer therapy on energetic capacity and body composition
Tarah J. Ballinger, Anurag Reddy, Sandra K. Althouse, Emily M. Nelson, Kathy D. Miller, Jeffrey S. Sledge
Associations of preoperative breast magnetic resonance imaging with subsequent mastectomy and breast cancer mortality
Shi-Yi Wang, Jessica B. Long, Brigid K. Killelea, Suzanne B. Evans, Kenneth B. Roberts, Andrea L. Silber, Amy J. Davidoff, Tannaz Sedghi, Cary P. Gross
Quantifying performance thresholds for recommending screening mammography: a revealed preference analysis of USPSTF guidelines
Anand K. Narayan, Elena B. Elkin, Constance D. Lehman, Elizabeth A. Morris
NRF1 motif sequence-enriched genes involved in ER/PR −ve HER2 +ve breast cancer signaling pathways
Jairo Ramos, Jayanta Das, Quentin Felty, Changwon Yoo, Robert Poppiti, Donna Murrell, Paula J. Foster, Deodutta Roy
Histopathologic characteristics of background parenchymal enhancement (BPE) on breast MRI
Janice S. Sung, Adriana D. Corben, Jennifer D. Brooks, Marcia Edelweiss, Delia M. Keating, Christine Lin, Elizabeth A. Morris, Prusha Patel, Mark Robson, Meghan Woods, Jonine L. Bernstein, Malcolm C. Pike
Substantial evidence for the clinical significance of missense variant BRCA1 c.5309G>T p.(Gly1770Val)
Emma Tudini, Setareh Moghadasi, Michael T. Parsons, Lizet van der Kolk, Ans M. W. van den Ouweland, Dieter Niederacher, Lídia Feliubadaló, Barbara Wappenschmidt, Amanda B. Spurdle, Conxi Lazaro
The association between estrogen receptor alpha gene rs746432 polymorphism and the risk of breast cancer
Bei Wang, Fenlai Yuan
Pure or mixed-type classical invasive lobular carcinoma might show different imaging features
Kadri Altundag
Elevated BMI might more significantly affect the outcome negatively in luminal type breast cancer patients with brain metastases
Kadri Altundag
Re: Elevated BMI might more significantly affect the outcome negatively in luminal type breast cancer patients with brain metastases
Brittany A. Simone, Kevin Ko, Nicole L. Simone